Gilead Sciences (GILD)
(Delayed Data from NSDQ)
$65.06 USD
+1.50 (2.36%)
Updated Jun 14, 2024 04:00 PM ET
After-Market: $65.26 +0.20 (0.31%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth B Momentum B VGM
Brokerage Reports
Gilead Sciences, Inc. [GILD]
Reports for Purchase
Showing records 521 - 525 ( 525 total )
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Previewing 4Q09:What to Watch for in 2010; Maintain Neutral
Provider: MERRIMAN CURHAN FORD & CO.
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Life Sciences - Biotechnology - Biotech Balance Sheet
Provider: MERRIMAN CURHAN FORD & CO.
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Biotech Balance Sheet
Provider: MERRIMAN CURHAN FORD & CO.
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Topline Phase II Quad vs. Atripla Meets Expectations
Provider: WEDBUSH SECURITIES INC.
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Biotech Balance Sheet
Provider: MERRIMAN CURHAN FORD & CO.